| Dr Jewel Bynoe Osborne-wu, MD | |
|
1050 Connecticut Ave Nw Ste 500, Washington, DC 20036-5304 | |
| (202) 596-8891 | |
| (833) 941-2357 |
| Full Name | Dr Jewel Bynoe Osborne-wu |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 12 Years |
| Location | 1050 Connecticut Ave Nw Ste 500, Washington, District Of Columbia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003175589 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Revolution Medicine Health And Fitness Pllc | 7911339890 | 6 |
| Inova Health Care Services | 2466351093 | 1725 |
| Neighborhood Health | 7517853419 | 43 |
| Revolution Medicine Health And Fitness Pllc | 7911339890 | 6 |
News Archive
As part of an ongoing effort to understand the biochemical basis of alcohol abuse, scientists at the U.S. Department of Energy's Brookhaven National Laboratory have published two studies on how modulating receptors for dopamine - a chemical "signaler" in the brain's reward circuits - affects drinking behavior in mice and rats.
Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., and Seattle Genetics, Inc. today announced interim data from a phase I clinical trial evaluating ASG-5ME for the treatment of castration-resistant prostate cancer.
The University of Southampton, in collaboration with Roke Manor Research Ltd (Roke), a Chemring company, has pioneered the use of Xbox computer technology to develop the world's first process that measures hand joint movement to help stroke patients recover manual agility at home.
Mobile Aspects, a leader in RFID enabled clinical process improvement systems, announced today that Novation, the health care contracting services company for VHA Inc., the University HealthSystem Consortium (UHC), and Provista, has awarded Mobile Aspects a three-year contract to supply radio frequency identification (RFID) inventory management systems to its member organizations.
Oncolytics Biotech Inc. announced today that the Cancer Therapy & Research Center at the University of Texas Health Science Center has started patient enrolment in a U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with carboplatin and paclitaxel in patients with squamous cell carcinoma of the lungs.
› Verified 8 days ago
| Entity Name | Revolution Medicine Health & Fitness Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245887959 PECOS PAC ID: 7911339890 Enrollment ID: O20210805002118 |
News Archive
As part of an ongoing effort to understand the biochemical basis of alcohol abuse, scientists at the U.S. Department of Energy's Brookhaven National Laboratory have published two studies on how modulating receptors for dopamine - a chemical "signaler" in the brain's reward circuits - affects drinking behavior in mice and rats.
Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., and Seattle Genetics, Inc. today announced interim data from a phase I clinical trial evaluating ASG-5ME for the treatment of castration-resistant prostate cancer.
The University of Southampton, in collaboration with Roke Manor Research Ltd (Roke), a Chemring company, has pioneered the use of Xbox computer technology to develop the world's first process that measures hand joint movement to help stroke patients recover manual agility at home.
Mobile Aspects, a leader in RFID enabled clinical process improvement systems, announced today that Novation, the health care contracting services company for VHA Inc., the University HealthSystem Consortium (UHC), and Provista, has awarded Mobile Aspects a three-year contract to supply radio frequency identification (RFID) inventory management systems to its member organizations.
Oncolytics Biotech Inc. announced today that the Cancer Therapy & Research Center at the University of Texas Health Science Center has started patient enrolment in a U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with carboplatin and paclitaxel in patients with squamous cell carcinoma of the lungs.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jewel Bynoe Osborne-wu, MD 1050 Connecticut Ave Nw Ste 500, Washington, DC 20036-5304 Ph: (202) 596-8891 | Dr Jewel Bynoe Osborne-wu, MD 1050 Connecticut Ave Nw Ste 500, Washington, DC 20036-5304 Ph: (202) 596-8891 |
News Archive
As part of an ongoing effort to understand the biochemical basis of alcohol abuse, scientists at the U.S. Department of Energy's Brookhaven National Laboratory have published two studies on how modulating receptors for dopamine - a chemical "signaler" in the brain's reward circuits - affects drinking behavior in mice and rats.
Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., and Seattle Genetics, Inc. today announced interim data from a phase I clinical trial evaluating ASG-5ME for the treatment of castration-resistant prostate cancer.
The University of Southampton, in collaboration with Roke Manor Research Ltd (Roke), a Chemring company, has pioneered the use of Xbox computer technology to develop the world's first process that measures hand joint movement to help stroke patients recover manual agility at home.
Mobile Aspects, a leader in RFID enabled clinical process improvement systems, announced today that Novation, the health care contracting services company for VHA Inc., the University HealthSystem Consortium (UHC), and Provista, has awarded Mobile Aspects a three-year contract to supply radio frequency identification (RFID) inventory management systems to its member organizations.
Oncolytics Biotech Inc. announced today that the Cancer Therapy & Research Center at the University of Texas Health Science Center has started patient enrolment in a U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with carboplatin and paclitaxel in patients with squamous cell carcinoma of the lungs.
› Verified 8 days ago
Dr. Ryan J. Montoya, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1225 4th St Ne, Washington, DC 20002 Phone: 202-763-7394 | |
Dr. Rufina Nwanneka Odigwe, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2139 Georgia Ave Nw, Suite 3b, Washington, DC 20001 Phone: 202-865-1452 | |
Miss Aruna Selina Harduarsingh-permaul, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3020 14th St Nw, Washington, DC 20009 Phone: 202-745-4300 | |
Dr. Lori A. Spoor, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1717 Columbia Rd Nw, Washington, DC 20009 Phone: 202-469-4699 Fax: 813-254-0230 | |
Dr. Keith Michael Egan, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 2nd St Ne, Washington, DC 20002 Phone: 202-346-3000 | |
Richard A Elion, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1701 14th Street Nw, Second Floor, Washington, DC 20009 Phone: 202-745-6142 Fax: 202-745-6152 |